AMACR

UniProt ID: Q9UHK6
Organism: Homo sapiens
Review Status: INITIALIZED
πŸ“ Provide Detailed Feedback

Gene Description

Alpha-methylacyl-CoA racemase (AMACR; EC 5.1.99.4) is an isomerase that interconverts the (R)- and (S)-epimers of 2-methyl-branched-chain fatty acyl-CoA esters. It acts only on coenzyme A thioesters (not free fatty acids) and accepts a wide range of alpha-methylacyl-CoA substrates including pristanoyl-CoA and the C27 bile-acid intermediates trihydroxycoprostanoyl-CoA (THCA-CoA) and DHCA-CoA, but not 3-methyl-branched or linear-chain acyl-CoAs. By converting (2R)-methyl-branched acyl-CoAs to their (S)-stereoisomers, AMACR generates the only stereoisomers that the peroxisomal beta-oxidation machinery can degrade, and is therefore essential for two catabolic routes; side-chain shortening of the C27 bile-acid intermediates (25R)-THCA-CoA and DHCA-CoA en route to the mature C24 bile acids, and degradation of the branched-chain fatty acid pristanic acid (the product of phytanic acid alpha-oxidation). The single AMACR transcript encodes a protein bearing two topogenic signals, a C-terminal PTS1 variant (KASL/ASL) and an internal mitochondrial targeting region, so the enzyme is dually localized to peroxisomes (bulk activity) and mitochondria, where a mitochondrial pool racemizes downstream pristanic-acid breakdown products. Loss-of-function variants cause AMACR deficiency, an adult-onset sensorimotor neuropathy and relapsing encephalopathy with elevated plasma pristanic acid and abnormal C27 bile-acid intermediates, and congenital bile acid synthesis defect type 4. AMACR is a member of the CoA-transferase III family and is a widely used immunohistochemical biomarker overexpressed in prostate and other carcinomas.

Existing Annotations Review

GO Term Evidence Action Reason
GO:0005739 mitochondrion
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) propagation of mitochondrial localization. AMACR is genuinely dual-localized to peroxisomes and mitochondria from a single transcript, and the mitochondrial pool has a demonstrated catalytic role in beta-oxidation of pristanic-acid breakdown products.
Reason: Direct experimental evidence supports mitochondrial localization and a mitochondrial catalytic role, consistent with this IBA propagation.
Supporting Evidence:
PMID:11060359
alpha-methylacyl-CoA racemase is bimodally distributed to both the peroxisome and the mitochondrion.
GO:0008111 alpha-methylacyl-CoA racemase activity
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) propagation of the defining molecular function, alpha-methylacyl-CoA racemase activity. This is the core, experimentally established function of AMACR.
Reason: Matches multiple experimental annotations (purified human enzyme, disease IMP) and the UniProt-curated catalytic activity; represents the core function.
Supporting Evidence:
PMID:7649182
accepts as substrates a wide range of alpha-methylacyl-CoAs, including pristanoyl-CoA and trihydroxycoprostanoyl-CoA (an intermediate in bile acid synthesis)
GO:0008206 bile acid metabolic process
IBA
GO_REF:0000033
ACCEPT
Summary: Phylogenetic (IBA) propagation placing AMACR in bile acid metabolism. AMACR racemizes the C27 bile-acid intermediate THCA-CoA/DHCA-CoA, a required step in bile-acid synthesis.
Reason: Consistent with experimental substrate data and disease phenotype (accumulation of C27 bile-acid intermediates on AMACR deficiency); genuine biological process.
Supporting Evidence:
PMID:7649182
trihydroxycoprostanoyl-CoA (an intermediate in bile acid synthesis)
GO:0003824 catalytic activity
IEA
GO_REF:0000002
MARK AS OVER ANNOTATED
Summary: InterPro2GO (IPR003673, CoA-transferase family III) maps to the generic root-level molecular function "catalytic activity".
Reason: Not wrong, but uninformative - the specific molecular function GO:0008111 (alpha-methylacyl-CoA racemase activity), supported by experimental evidence, fully supersedes this generic parent term.
Supporting Evidence:
PMID:7649182
accepts as substrates a wide range of alpha-methylacyl-CoAs
GO:0005739 mitochondrion
IEA
GO_REF:0000044
ACCEPT
Summary: UniProt subcellular-location keyword mapping (SL-0173, Mitochondrion) to GO. Consistent with the curated SUBCELLULAR LOCATION and with experimental evidence for a mitochondrial AMACR pool.
Reason: AMACR carries an internal mitochondrial targeting signal and a mitochondrial catalytic role is experimentally established; the keyword mapping is correct.
Supporting Evidence:
PMID:11060344
mitochondrial targeting information is localized between amino acids 22 and 85
GO:0005777 peroxisome
IEA
GO_REF:0000044
ACCEPT
Summary: UniProt subcellular-location keyword mapping (SL-0204, Peroxisome) to GO. Peroxisome is the major site of AMACR activity.
Reason: Matches multiple experimental peroxisomal-localization annotations and the curated SUBCELLULAR LOCATION; the bulk of racemase activity is peroxisomal.
Supporting Evidence:
PMID:7649182
the bulk activity was located in peroxisomes
GO:0008111 alpha-methylacyl-CoA racemase activity
IEA
GO_REF:0000120
ACCEPT
Summary: Automated (RHEA/EC 5.1.99.4) mapping to the defining racemase activity. Redundant with the experimental annotations of the same term but correct.
Reason: The RHEA:12657 / EC 5.1.99.4 mapping correctly captures the core catalytic function, which is experimentally validated.
Supporting Evidence:
PMID:7649182
A specific racemase for alpha-methylacyl-CoAs
GO:0006699 bile acid biosynthetic process
TAS
Reactome:R-HSA-193368
ACCEPT
Summary: Reactome pathway (synthesis of bile acids via 7alpha-hydroxycholesterol) places AMACR in bile-acid biosynthesis via racemization of the C27 intermediate.
Reason: AMACR racemizes (25R)-THCA-CoA to the (25S) form required for peroxisomal side-chain shortening to C24 bile acids; core biosynthetic role.
Supporting Evidence:
PMID:10655068
This enzyme is responsible for the conversion of pristanoyl-CoA and C27-bile acyl-CoAs to their (S)-stereoisomers
GO:0006699 bile acid biosynthetic process
TAS
Reactome:R-HSA-193775
ACCEPT
Summary: Reactome pathway (synthesis of bile acids via 24-hydroxycholesterol) places AMACR in bile-acid biosynthesis. Duplicate of the biosynthetic-process annotation from a parallel Reactome route.
Reason: Same core biosynthetic role via racemization of C27 bile-acid intermediates; correct.
Supporting Evidence:
PMID:10655068
This enzyme is responsible for the conversion of pristanoyl-CoA and C27-bile acyl-CoAs to their (S)-stereoisomers
GO:0033540 fatty acid beta-oxidation using acyl-CoA oxidase
TAS
Reactome:R-HSA-389887
ACCEPT
Summary: Reactome pathway (beta-oxidation of pristanoyl-CoA) places AMACR in peroxisomal branched-chain fatty acid beta-oxidation. AMACR produces the (S)-pristanoyl-CoA that the acyl-CoA oxidase step can act on.
Reason: AMACR racemizes (2R)-pristanoyl-CoA to (2S)-pristanoyl-CoA, an obligatory step upstream of peroxisomal acyl-CoA-oxidase-dependent beta-oxidation of pristanic acid; core catabolic role.
Supporting Evidence:
PMID:11060344
is an auxiliary enzyme required for the peroxisomal beta-oxidative breakdown of (2R)-pristanic acid
GO:0006631 fatty acid metabolic process
IEA
GO_REF:0000041
ACCEPT
Summary: UniPathway mapping (UPA00199, fatty acid metabolism) to the broad fatty acid metabolic process term.
Reason: Correct though general; AMACR participates in branched-chain fatty acid (pristanic acid) metabolism. Retained as a broad parent of the more specific beta-oxidation role.
Supporting Evidence:
PMID:11060359
plays an important role in the beta-oxidation of branched-chain fatty acids and fatty acid derivatives
GO:0006699 bile acid biosynthetic process
IEA
GO_REF:0000041
ACCEPT
Summary: UniPathway mapping (UPA00221, bile acid biosynthesis) to bile-acid biosynthetic process. Redundant with the Reactome TAS annotations of the same term.
Reason: Correctly captures AMACR's role in bile-acid biosynthesis via C27 intermediate racemization.
Supporting Evidence:
PMID:10655068
elevated plasma concentrations of pristanic acid (a branched-chain fatty acid) and C27-bile-acid intermediates
GO:0008111 alpha-methylacyl-CoA racemase activity
EXP
PMID:7649182
Purification and characterization of an alpha-methylacyl-CoA...
ACCEPT
Summary: Experimental characterization of the purified human liver enzyme demonstrating alpha-methylacyl-CoA racemase activity. Core, defining molecular function.
Reason: Enzyme purified ~3600-fold from human liver and shown to racemize alpha-methylacyl-CoA substrates; direct experimental basis for the core function.
Supporting Evidence:
PMID:7649182
A specific racemase for alpha-methylacyl-CoAs, which had previously been studied in rat liver
GO:0008111 alpha-methylacyl-CoA racemase activity
TAS
Reactome:R-HSA-192056
ACCEPT
Summary: Reactome (isomerization of 25(R) THCA-CoA to 25(S) THCA-CoA) asserts the racemase activity on a specific bile-acid intermediate substrate.
Reason: Correctly captures the core racemase activity acting on the C27 bile-acid intermediate THCA-CoA.
Supporting Evidence:
PMID:7649182
trihydroxycoprostanoyl-CoA (an intermediate in bile acid synthesis)
GO:0008111 alpha-methylacyl-CoA racemase activity
TAS
Reactome:R-HSA-193452
ACCEPT
Summary: Reactome (isomerization of 25(R) DHCA-CoA to 25(S) DHCA-CoA) asserts the racemase activity on the DHCA-CoA bile-acid intermediate.
Reason: Correctly captures the core racemase activity acting on a C27 bile-acid intermediate.
Supporting Evidence:
PMID:10655068
conversion of pristanoyl-CoA and C27-bile acyl-CoAs to their (S)-stereoisomers
GO:0008111 alpha-methylacyl-CoA racemase activity
TAS
Reactome:R-HSA-193736
ACCEPT
Summary: Reactome (isomerization of 3,7,24-THCA-CoA) asserts racemase activity on a bile-acid intermediate. Duplicate assertion of the core function.
Reason: Correctly captures the core racemase activity.
Supporting Evidence:
PMID:7649182
A specific racemase for alpha-methylacyl-CoAs
GO:0008111 alpha-methylacyl-CoA racemase activity
TAS
Reactome:R-HSA-193763
ACCEPT
Summary: Reactome assertion of AMACR racemase activity within the bile-acid synthesis pathway. Duplicate assertion of the core function.
Reason: Correctly captures the core racemase activity.
Supporting Evidence:
PMID:7649182
A specific racemase for alpha-methylacyl-CoAs
GO:0005777 peroxisome
IDA
GO_REF:0000052
ACCEPT
Summary: Immunofluorescence (Human Protein Atlas) localizing AMACR to the peroxisome. Consistent with the major site of racemase activity.
Reason: Peroxisomal localization is the dominant, experimentally supported location of AMACR; core.
Supporting Evidence:
PMID:7649182
the bulk activity was located in peroxisomes
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-192056
ACCEPT
Summary: Reactome places AMACR in the peroxisomal matrix, the soluble compartment where matrix enzymes act after PTS1-mediated import.
Reason: AMACR is a soluble matrix enzyme imported via its C-terminal PTS1 variant; peroxisomal matrix is the precise location.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-193452
ACCEPT
Summary: Reactome peroxisomal-matrix localization (DHCA-CoA isomerization context). Duplicate of the peroxisomal-matrix location.
Reason: Consistent precise matrix localization for this soluble PTS1-imported enzyme.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-193736
ACCEPT
Summary: Reactome peroxisomal-matrix localization (3,7,24-THCA-CoA context). Duplicate of the peroxisomal-matrix location.
Reason: Consistent precise matrix localization for this soluble PTS1-imported enzyme.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-193763
ACCEPT
Summary: Reactome peroxisomal-matrix localization. Duplicate of the peroxisomal-matrix location.
Reason: Consistent precise matrix localization for this soluble PTS1-imported enzyme.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-389897
ACCEPT
Summary: Reactome peroxisomal-matrix localization (pristanoyl-CoA isomerization context). Duplicate of the peroxisomal-matrix location.
Reason: Consistent precise matrix localization for this soluble PTS1-imported enzyme.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005782 peroxisomal matrix
TAS
Reactome:R-HSA-9033235
ACCEPT
Summary: Reactome peroxisomal-matrix localization (peroxisomal import context). Duplicate of the peroxisomal-matrix location.
Reason: Consistent precise matrix localization for this soluble PTS1-imported enzyme.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005739 mitochondrion
HTP
PMID:34800366
Quantitative high-confidence human mitochondrial proteome an...
UNDECIDED
Summary: High-throughput mitochondrial-proteome study. AMACR is not named in the cached abstract/text; the supporting evidence would be in large-scale supplementary data that cannot be verified from the cache.
Reason: Cannot verify the AMACR-specific evidence from the cached publication (large-scale HTP dataset, gene not mentioned in available text). Mitochondrial localization is independently well supported by the experimental IDA/EXP annotations, so this HTP hit is plausibly correct but is left UNDECIDED for lack of verifiable cached evidence.
GO:0005739 mitochondrion
EXP
PMID:11060344
Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA ...
ACCEPT
Summary: Experimental study of AMACR targeting demonstrating an internal mitochondrial targeting signal (aa 22-85) and dual peroxisomal/mitochondrial localization from a single transcript.
Reason: Direct experimental evidence for mitochondrial targeting and localization of AMACR.
Supporting Evidence:
PMID:11060344
a single transcript gives rise to a racemase protein containing two topogenic signals, explaining the dual cellular localization of the activity
GO:0005777 peroxisome
EXP
PMID:11060344
Mitochondrial and peroxisomal targeting of 2-methylacyl-CoA ...
ACCEPT
Summary: Experimental study demonstrating peroxisomal targeting of AMACR via a novel C-terminal PTS1 variant (ASL).
Reason: Direct experimental evidence for peroxisomal targeting/localization; core location.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005739 mitochondrion
IDA
PMID:11060359
Subcellular localization and physiological role of alpha-met...
ACCEPT
Summary: Direct assay evidence for bimodal peroxisomal/mitochondrial distribution of AMACR, with a demonstrated mitochondrial catalytic role.
Reason: Experimentally established mitochondrial localization with a functional mitochondrial beta-oxidation role.
Supporting Evidence:
PMID:11060359
alpha-methylacyl-CoA racemase is bimodally distributed to both the peroxisome and the mitochondrion
GO:0005777 peroxisome
IDA
PMID:11060359
Subcellular localization and physiological role of alpha-met...
ACCEPT
Summary: Direct assay evidence for peroxisomal localization of AMACR as part of its bimodal distribution.
Reason: Experimentally established peroxisomal localization; core location.
Supporting Evidence:
PMID:11060359
alpha-methylacyl-CoA racemase is bimodally distributed to both the peroxisome and the mitochondrion
GO:0008111 alpha-methylacyl-CoA racemase activity
IDA
PMID:11060359
Subcellular localization and physiological role of alpha-met...
ACCEPT
Summary: Direct assay of racemase activity, including demonstration that the mitochondrial enzyme racemizes (2R,6)-dimethylheptanoyl-CoA. Core molecular function.
Reason: Direct experimental demonstration of alpha-methylacyl-CoA racemase activity.
Supporting Evidence:
PMID:11060359
converting (2R,6)-dimethylheptanoyl-CoA to its (S)-stereoisomer
GO:0005829 cytosol
TAS
Reactome:R-HSA-9033235
MARK AS OVER ANNOTATED
Summary: Reactome "cytosol" localization arising from the peroxisomal protein-import reaction (cargo translocates from cytosol to peroxisomal matrix). This reflects a transient import intermediate, not a functional cytosolic pool.
Reason: AMACR is a PTS1-targeted matrix enzyme; its appearance in the cytosol is the pre-import transit state modeled by Reactome's import pathway, not a site where the enzyme carries out its function. The functional locations are peroxisome and mitochondrion.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005829 cytosol
TAS
Reactome:R-HSA-9033236
MARK AS OVER ANNOTATED
Summary: Reactome "cytosol" localization from the peroxisomal docking/translocation import step (PEX5:cargo binding the docking module). Transient import intermediate, not a functional cytosolic pool.
Reason: Same as the other cytosol annotation - reflects the pre-import transit state modeled by the peroxisomal-import pathway rather than a functional cytosolic localization.
Supporting Evidence:
PMID:11060344
ASL is a new PTS1 variant
GO:0005739 mitochondrion
IDA
PMID:20102405
How useful is alpha-methylacyl-CoA racemase (AMACR) immunohi...
ACCEPT
Summary: Immunohistochemistry-based localization in a kidney-cancer diagnostic context (a Comment/Letter). Mitochondrial localization is independently well established.
Reason: Mitochondrial localization of AMACR is robustly supported by multiple experimental studies; this IHC-based annotation is consistent with the established dual localization.
Supporting Evidence:
PMID:11060359
alpha-methylacyl-CoA racemase is bimodally distributed to both the peroxisome and the mitochondrion
GO:0008111 alpha-methylacyl-CoA racemase activity
IMP
PMID:10655068
Mutations in the gene encoding peroxisomal alpha-methylacyl-...
ACCEPT
Summary: Mutational (IMP) evidence - patients with AMACR deficiency accumulate pristanic acid and C27 bile-acid intermediates, and disease-causing variants (e.g. S52P) inactivate the enzyme, establishing that AMACR provides the racemase activity in vivo.
Reason: Loss-of-function variants abolish racemization of pristanoyl-CoA and C27-bile acyl-CoAs, directly linking AMACR to alpha-methylacyl-CoA racemase activity; core function.
Supporting Evidence:
PMID:10655068
This enzyme is responsible for the conversion of pristanoyl-CoA and C27-bile acyl-CoAs to their (S)-stereoisomers
GO:0005737 cytoplasm
IDA
PMID:15941950
Alpha-methylacyl-CoA racemase protein expression is associat...
MARK AS OVER ANNOTATED
Summary: Breast-cancer immunohistochemistry study reporting AMACR in cytoplasmic granules consistent with mitochondrial and peroxisomal localization. The generic "cytoplasm" term is a parent of the specific organelle locations.
Reason: The study itself attributes the cytoplasmic-granule staining to peroxisomes/mitochondria; the specific organelle terms (peroxisome, mitochondrion) already capture this, so the generic cytoplasm term is an over-annotation.
Supporting Evidence:
PMID:15941950
AMACR was seen in cytoplasmic granules consistent with a mitochondrial and peroxisomal localization
GO:0008206 bile acid metabolic process
IDA
PMID:10655068
Mutations in the gene encoding peroxisomal alpha-methylacyl-...
ACCEPT
Summary: Direct evidence linking AMACR to bile-acid metabolism - AMACR-deficient patients accumulate C27 bile-acid intermediates that are AMACR substrates.
Reason: Establishes AMACR's role in bile-acid metabolism via racemization of C27 bile-acid intermediates required for their onward degradation to C24 bile acids.
Supporting Evidence:
PMID:10655068
elevated plasma concentrations of pristanic acid (a branched-chain fatty acid) and C27-bile-acid intermediates
GO:0005739 mitochondrion
IDA
PMID:7649182
Purification and characterization of an alpha-methylacyl-CoA...
ACCEPT
Summary: Subcellular fractionation of human tissues showing 10-30% of racemase activity in mitochondria (with the bulk in peroxisomes).
Reason: Direct fractionation evidence for a mitochondrial AMACR pool; consistent with the established dual localization.
Supporting Evidence:
PMID:7649182
only 10-30% of the activity was found in mitochondria
GO:0005777 peroxisome
IDA
PMID:7649182
Purification and characterization of an alpha-methylacyl-CoA...
ACCEPT
Summary: Subcellular fractionation of human tissues showing the bulk of racemase activity in peroxisomes; peroxisomal form absent in Zellweger (peroxisome-assembly-deficient) cells.
Reason: Direct fractionation evidence that peroxisome is the dominant AMACR localization; core location.
Supporting Evidence:
PMID:7649182
the bulk activity was located in peroxisomes
GO:0008111 alpha-methylacyl-CoA racemase activity
IDA
PMID:7649182
Purification and characterization of an alpha-methylacyl-CoA...
ACCEPT
Summary: Purification and direct enzymatic characterization of AMACR from human liver, establishing alpha-methylacyl-CoA racemase activity on CoA thioesters. This is the primary experimental basis for the core function.
Reason: Purified human enzyme directly shown to racemize alpha-methylacyl-CoA substrates; defining core molecular function.
Supporting Evidence:
PMID:7649182
It acts only on coenzyme A thioesters, not on free fatty acids, and accepts as substrates a wide range of alpha-methylacyl-CoAs

Core Functions

Interconverts the (R)- and (S)-epimers of 2-methyl-branched-chain acyl-CoA esters (alpha-methylacyl-CoA racemase, EC 5.1.99.4), converting (2R)-methyl-branched acyl-CoAs to the (S)-stereoisomers required by peroxisomal beta-oxidation. Essential for side-chain shortening of the C27 bile-acid intermediates (25R)-THCA-CoA/DHCA-CoA en route to C24 bile acids, and for degradation of the branched-chain fatty acid pristanic acid. Acts as a soluble matrix enzyme in the peroxisome (and a mitochondrial pool).

Supporting Evidence:
  • PMID:7649182
    It acts only on coenzyme A thioesters, not on free fatty acids, and accepts as substrates a wide range of alpha-methylacyl-CoAs, including pristanoyl-CoA and trihydroxycoprostanoyl-CoA (an intermediate in bile acid synthesis)
  • PMID:10655068
    This enzyme is responsible for the conversion of pristanoyl-CoA and C27-bile acyl-CoAs to their (S)-stereoisomers, which are the only stereoisomers that can be degraded via peroxisomal beta-oxidation

References

Loading supporting content…

Download this section (compressed HTML)

πŸ“š Additional Documentation

Notes

(AMACR-notes.md)

Loading supporting content…

Download this section (compressed HTML)

πŸ“„ View Raw YAML

Loading supporting content…

Download this section (compressed HTML)